Stay updated with breaking news from Nasdaq Pstv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Plus Therapeutics, Inc. (NASDAQ:PSTV – Get Free Report) was the target of a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 43,300 shares, a decline of 25.3% from the January 15th total of 58,000 shares. Currently, 1.0% of the shares of the company are […]
Plus Therapeutics (NASDAQ:PSTV – Get Free Report) and SANUWAVE Health (OTCMKTS:SNWV – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, earnings, risk, valuation, institutional ownership and profitability. Insider & Institutional Ownership 3.5% of Plus […]
Plus Therapeutics, Inc. (NASDAQ:PSTV – Get Free Report) Director Greg Petersen purchased 20,000 shares of the company’s stock in a transaction on Monday, September 11th. The stock was bought at an average price of $1.70 per share, for a total transaction of $34,000.00. Following the completion of the purchase, the director now directly owns 24,166 […]
Plus Therapeutics, Inc. (NASDAQ:PSTV – Free Report) – Research analysts at HC Wainwright upped their Q3 2023 earnings per share (EPS) estimates for shares of Plus Therapeutics in a research note issued on Tuesday, August 15th. HC Wainwright analyst S. Lee now forecasts that the company will earn ($0.58) per share for the quarter, up […]
Trial investigators and company management to discuss latest data from the ReSPECT-LM leptomeningeal metastases clinical trial Webinar scheduled for...